发明名称 KIT FOR TREATMENT OF LOWER URINARY TRACT DISORDER, AND IMPROVED COMPOSITION
摘要 <P>PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for treatment, improvement, and prevention of lower urinary tract disorder. <P>SOLUTION: The pharmaceutical composition contains : (a) anionic polysaccharide in an amount suficient to treat, improve, and prevent the lower urinary tract disorder ; (b) acute action anesthetic drug in an amount sufficient to treat, improve, and prevent the lower urinary tract disorder ; and (c) buffer solution for buffering the solution to adjust its pH so as to enable a sufficient portion of the acute action anesthetic drug to be in a noncharged state so that the acute action anesthetic drug can pass through cell membrannes. When a formulation is dissolved in an aqueous liquid for administration, the buffer solution having 0.20-0.45M level of sodium hydrogen carbonate is contained. It is desirable that the anionic polysaccharide is selected from a group of hyaluronic acid, hyaluronan, chondroitin sulfate, pentosan polysulfate, dermatan sulfate, heparin, heparan sulfate, and keratan sulfate. Lidcaine is desirable as the acute action anesthetic drug. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2013028625(A) 申请公布日期 2013.02.07
申请号 JP20120204288 申请日期 2012.09.18
申请人 URIGEN INC 发明人 FLASHNER MICHAEL;FRANKLIN AMIE;GARNER WILLIAM;PARSONS C;SEMBER MICHAEL
分类号 A61K31/715;A61K9/08;A61K31/137;A61K31/167;A61K31/18;A61K31/365;A61K31/4174;A61K31/4196;A61K31/43;A61K31/47;A61K31/496;A61K31/505;A61K31/545;A61K31/635;A61K31/65;A61K31/7048;A61K31/726;A61K31/727;A61K31/728;A61K45/00;A61K45/06;A61K47/02;A61K47/10;A61K47/18;A61K47/22;A61K47/32;A61K47/34;A61K47/36;A61P9/00;A61P13/02;A61P13/08;A61P13/10;A61P15/00;A61P23/02;A61P29/00;A61P31/04;A61P31/10;A61P43/00 主分类号 A61K31/715
代理机构 代理人
主权项
地址